{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:24:15Z","timestamp":1766690655565,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004205, 82174308"],"award-info":[{"award-number":["82004205, 82174308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Spring Sunshine Program of Scientific Research Cooperation, Ministry of Education of China","award":["HZKY20220109"],"award-info":[{"award-number":["HZKY20220109"]}]},{"name":"National Administration of Traditional Chinese medicine, P.R. China","award":["2023ZYLCYJ02-18"],"award-info":[{"award-number":["2023ZYLCYJ02-18"]}]},{"name":"Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine","award":["BJ2022KY11"],"award-info":[{"award-number":["BJ2022KY11"]}]},{"name":"the Science and Technology Research Fund from Guangdong provincial hospital of Chinese medicine, China","award":["YN2024MS012, YN2020QN18, YN2020QN24"],"award-info":[{"award-number":["YN2024MS012, YN2020QN18, YN2020QN24"]}]},{"name":"the Karolinska Institutet\u2019s research grant","award":["2020-01616, 2022-02044"],"award-info":[{"award-number":["2020-01616, 2022-02044"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZZYSM202206014"],"award-info":[{"award-number":["SZZYSM202206014"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK115534","R01DK115534"],"award-info":[{"award-number":["R01DK115534","R01DK115534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","award":["2023-01807"],"award-info":[{"award-number":["2023-01807"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Swedish Heart and Lung Foundation","award":["20230371"],"award-info":[{"award-number":["20230371"]}]},{"name":"Region Stockholm","award":["ALF Medicine, FoUI-986028"],"award-info":[{"award-number":["ALF Medicine, FoUI-986028"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anemia is common in patients with heart failure (HF). Although iron testing is recommended, it is uncertain that solely emphasizing iron testing could result in lesser attention to other causes, like bleeding or cancer. This study aimed to evaluate the diagnostic work-up of incident anemia in patients with HF in routine care and associated health outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Observational study of 8932 non-anemic adults with HF in Stockholm, Sweden, was quantified for incidence of anemia, diagnostic work-up (recognition, laboratory\/invasive testing) and treatment across severity of anemia and setting of care. Time-varying Cox regression explored associations between developing anemia and rate of major adverse cardiovascular events (MACE), HF hospitalization, cancer, and death.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During median 2.7 years, 34% of patients developed\u00a0incident anemia, and 13% developed severe anemia. Within 6 months from incident anemia, ferritin and transferrin saturation were tested in 44% overall and 65% of severe cases. Testing of liver enzymes, creatinine, and C-reactive protein was, however, done in\u2009&gt;\u200990% of cases. Colonoscopy, esophagogastroduodenoscopy, urinalysis, and cystoscopy were performed in 2\u201310% of cases. Few patients were recognized with an ICD code diagnosis of anemia (16%). Treatments were infrequent: oral iron (10%), intravenous iron (16%), blood transfusions (6%), and erythropoietin-stimulating agents (&lt;\u20091%). More anemia cases received treatment in cardiology care (43%) versus primary care (29%). New-onset anemia was associated with risk of MACE (adjusted HR 2.13, 95% CI 1.85\u20132.44), HF hospitalization (4.85, 4.30\u20135.48), cancer (3.41, 3.09\u20133.77), and death (2.04, 1.82\u20132.29).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>One in three patients with HF experienced anemia, which was associated with adverse health outcomes. Testing for iron stores and invasive work-up was suboptimal. A large proportion of anemia events remained under-recognized and untreated, a pattern of care that warrants correction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-04303-8","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:19:55Z","timestamp":1755001195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic work-up of anemia and associated health outcomes in people with heart failure"],"prefix":"10.1186","volume":"23","author":[{"given":"Guobin","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruowei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongze","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hallert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jesus","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"9","key":"4303_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nrcardio.2011.77","volume":"8","author":"DJ van Veldhuisen","year":"2011","unstructured":"van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011;8(9):485\u201393.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"4303_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","volume":"106","author":"S von Haehling","year":"2017","unstructured":"von Haehling S, Gremmler U, Krumm M, Mibach F, Sch\u00f6n N, Taggeselle J, et al. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP registry. Clin Res Cardiol. 2017;106(6):436\u201343.","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"4303_CR3","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/ejhf.2338","volume":"23","author":"PM Becher","year":"2021","unstructured":"Becher PM, Schrage B, Benson L, Fudim M, Corovic Cabrera C, Dahlstr\u00f6m U, et al. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry. Eur J Heart Fail. 2021;23(11):1844\u201354.","journal-title":"Eur J Heart Fail"},{"key":"4303_CR4","doi-asserted-by":"crossref","unstructured":"Kido K, Beavers CJ, Dulnuan K, Fida N, Guglin M, Ilonze OJ, et al. Management of iron deficiency in heart failure: practical considerations and implementation of evidence-based iron supplementation. JACC Heart Fail. 2024;12(11):1956\u201360.","DOI":"10.1016\/j.jchf.2024.05.014"},{"issue":"4","key":"4303_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ehjqcco\/qcz010","volume":"5","author":"AP Ambrosy","year":"2019","unstructured":"Ambrosy AP, Gurwitz JH, Tabada GH, Artz A, Schrier S, Rao SV, et al. Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes. Eur Heart J Qual Care Clin Outcomes. 2019;5(4):361\u20139.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"4303_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","volume":"44","author":"G Savarese","year":"2023","unstructured":"Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J. 2023;44(1):14\u201327.","journal-title":"Eur Heart J"},{"issue":"8","key":"4303_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891\u2013975.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"4303_CR8","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ejhf.2879","volume":"25","author":"F Lindberg","year":"2023","unstructured":"Lindberg F, Lund LH, Benson L, Linde C, Orsini N, Carrero JJ, et al. Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project. Eur J Heart Fail. 2023;25(8):1270\u201380.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"4303_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2007.07.094","volume":"51","author":"WH Tang","year":"2008","unstructured":"Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2008;51(5):569\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"4303_CR10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/eurheartj\/ehl012","volume":"27","author":"M Komajda","year":"2006","unstructured":"Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J. 2006;27(12):1440\u20136.","journal-title":"Eur Heart J"},{"issue":"3","key":"4303_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2004.10.038","volume":"45","author":"A Ishani","year":"2005","unstructured":"Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45(3):391\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"4303_CR12","doi-asserted-by":"crossref","unstructured":"Ugarph-Morawski A, W\u00e4ndell P, Benson L, Savarese G, Lund LH, Dahlstr\u00f6m U, et al. The association between anemia, hospitalization, and all-cause mortality in patients with heart failure managed in primary care: an analysis of the Swedish heart failure registry. Arch Gerontol Geriatr. 2025;129:105645.","DOI":"10.1016\/j.archger.2024.105645"},{"issue":"3","key":"4303_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/joim.13418","volume":"291","author":"JJ Carrero","year":"2022","unstructured":"Carrero JJ, Elinder CG. The Stockholm CREAtinine Measurements (SCREAM) project: fostering improvements in chronic kidney disease care. J Intern Med. 2022;291(3):254\u201368.","journal-title":"J Intern Med"},{"issue":"2","key":"4303_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Micha\u00eblsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125\u201336.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"4303_CR15","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1002\/ehf2.12779","volume":"7","author":"A Uijl","year":"2020","unstructured":"Uijl A, Lund LH, Vaartjes I, Brugts JJ, Linssen GC, Asselbergs FW, et al. A registry-based algorithm to predict ejection fraction in patients with heart failure. ESC Heart Fail. 2020;7(5):2388\u201397.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"4303_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"4303_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ejhf.2251","volume":"24","author":"FJ Graham","year":"2021","unstructured":"Graham FJ, Masini G, Pellicori P, Cleland JGF, Greenlaw N, Friday J, et al. Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. Eur J Heart Fail. 2021;24(5):807\u201317.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"4303_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ehf2.12279","volume":"5","author":"VJ Goh","year":"2018","unstructured":"Goh VJ, Tromp J, Teng THK, Tay WT, Van Der Meer P, Ling LH, et al. Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic Asian patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2018;5(4):570\u20138.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"4303_CR19","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00392-024-02518-y","volume":"113","author":"J \u010celutkien\u0117","year":"2024","unstructured":"\u010celutkien\u0117 J, \u010cerlinskait\u0117-Bajor\u0117 K, Cotter G, Edwards C, Adamo M, Arrigo M, et al. Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study. Clin Res Cardiol. 2024;113(11):1589\u2013603.","journal-title":"Clin Res Cardiol"},{"issue":"37","key":"4303_CR20","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J"},{"key":"4303_CR21","doi-asserted-by":"crossref","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022;145(18): e876-e894.","DOI":"10.1161\/CIR.0000000000001073"},{"issue":"3","key":"4303_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2020.06.046","volume":"159","author":"CW Ko","year":"2020","unstructured":"Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, et al. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159(3):1085\u201394.","journal-title":"Gastroenterology"},{"key":"4303_CR23","unstructured":"Excellence NIfHaC. Suspected cancer: recognition and referral: National Institute for Health and Care Excellence: Guidelines.; 2023 Oct 24."},{"issue":"4","key":"4303_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","volume":"104","author":"E Ku","year":"2023","unstructured":"Ku E, Del Vecchio L, Eckardt K-U, Haase VH, Johansen KL, Nangaku M, et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2023;104(4):655\u201380.","journal-title":"Kidney Int"},{"issue":"11","key":"4303_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, et al. Ferric carboxymaltose in heart failure with iron deficiency. N Engl J Med. 2023;389(11):975\u201386.","journal-title":"N Engl J Med"},{"issue":"13","key":"4303_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","volume":"368","author":"K Swedberg","year":"2013","unstructured":"Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;368(13):1210\u20139.","journal-title":"N Engl J Med"},{"key":"4303_CR27","doi-asserted-by":"crossref","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20): 2085-2098.","DOI":"10.1056\/NEJMoa065485"},{"issue":"20","key":"4303_CR28","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Dr\u00fceke","year":"2006","unstructured":"Dr\u00fceke TB, Locatelli F, Clyne N, Eckardt K-U, Macdougall IC, Tsakiris D, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355(20):2071\u201384.","journal-title":"N Engl J Med"},{"key":"4303_CR29","doi-asserted-by":"crossref","unstructured":"Wetmore JB, Weinhandl ED, Yan H, Reyes JL, Herzog CA, Roetker NS. Apixaban dosing patterns versus warfarin in patients with nonvalvular atrial fibrillation receiving dialysis: a retrospective cohort study. Am J Kidney Dis. 2022;80(5):569-79.e1.","DOI":"10.1053\/j.ajkd.2022.03.007"},{"issue":"08","key":"4303_CR30","first-page":"808","volume":"39","author":"AK Lewkowitz","year":"2021","unstructured":"Lewkowitz AK, Stout MJ, Cooke E, Deoni SC, D\u2019Sa V, Rouse DJ, et al. Intravenous versus oral iron for iron-deficiency anemia in pregnancy (IVIDA): a randomized controlled trial. Am J Perinatol. 2021;39(08):808\u201315.","journal-title":"Am J Perinatol"},{"issue":"1","key":"4303_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2022;24(1):4\u2013131.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4303_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119647","volume":"10","author":"N Hung","year":"2015","unstructured":"Hung N, Shen CC, Hu YW, Hu LY, Yeh CM, Teng CJ, et al. Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study. PLoS One. 2015;10(3): e0119647.","journal-title":"PLoS One"},{"issue":"7","key":"4303_CR33","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1158\/1055-9965.EPI-20-1840","volume":"30","author":"TK Oh","year":"2021","unstructured":"Oh TK, Song IA. Anemia may increase the overall risk of cancer: findings from a cohort study with a 12-year follow-up period in South Korea. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1440\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04303-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:42:16Z","timestamp":1757418136000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4303"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04303-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"type":"electronic","value":"1741-7015"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Ethics Review Board in Stockholm approved the study; informed participant consent was not deemed necessary since all data were de-identified at the Swedish Board of Health and Welfare (reference 2017\/793-31).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"G.S2. reports grants and personal fees from CSL Vifor, Boehringer Ingelheim, AstraZeneca, Servier, Novartis, Cytokinetics, Pharmacosmos, Medtronic, Bayer, and personal fees from Roche, Abbott, Edwards Lifescience, TEVA, Menarini, INTAS, GETZ, and grants from Boston Scientific, Merck, all outside the submitted work. Unrelated to the present manuscript: Grants, consulting, speakers honoraria to authors institution: Alleviant, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Edwards, Owkin, Pharmacosmos. Other authors have no competing interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}